Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Biesecker Lab/Clinical Genomics Section, |
RCV000172608 | SCV000051308 | likely benign | not provided | 2013-06-24 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001079964 | SCV000555248 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2025-02-02 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000172608 | SCV000708842 | uncertain significance | not provided | 2017-05-24 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000172608 | SCV001785586 | likely benign | not provided | 2021-06-16 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25163546) |
CHEO Genetics Diagnostic Laboratory, |
RCV001798621 | SCV002043087 | benign | Cardiomyopathy | 2020-12-08 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002372079 | SCV002667927 | benign | Cardiovascular phenotype | 2020-05-28 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000172608 | SCV003818539 | uncertain significance | not provided | 2022-06-14 | criteria provided, single submitter | clinical testing |